Literature DB >> 3778542

Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis.

T E Mollnes, A Paus.   

Abstract

Synovial fluid (SF) and synovial tissue from 10 patients with juvenile rheumatoid arthritis were examined. The SFs were heterogeneous with respect to the degree of complement activation. Quantification of C3dg and the terminal complement complex revealed a positive correlation between activation of the early and the late parts of the cascade in all patients. The amount of C-reactive protein and the number of white blood cells in the SF correlated significantly with the degree of complement activation. Weak deposits of C3, C3dg, or terminal complement complex were observed in a few vessels in the synovial tissue from 5 of the patients. There was no correlation between complement activity in SF and in the corresponding tissue. Furthermore, there was no correlation between clinical activity in the joints and the degree of complement activation. It is concluded that there is a discrepancy between synovial tissue and synovial fluid with respect to complement activation. C-reactive protein may, to some extent, be responsible for activation in SF, and the accumulation of white blood cells may be due to complement activation products.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3778542     DOI: 10.1002/art.1780291108

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

2.  Measurement of complement activation products in patients with chronic rheumatic diseases.

Authors:  G Auda; E R Holme; J E Davidson; A Zoma; J Veitch; K Whaley
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 3.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

4.  Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA.

Authors:  B Jahn; J Von Kempis; K L Krämer; S Filsinger; G M Hänsch
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

Review 5.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

6.  Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis.

Authors:  Nicole L Tramontini; Paul J Kuipers; Colleen M Huber; Kerri Murphy; Keith B Naylor; Autumn J Broady; Kenneth S Kilgore
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

7.  In vivo clearance studies of the terminal fluid-phase complement complex in rabbits.

Authors:  F Hugo; C Berstecher; S Krämer; W Fassbender; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

8.  IgE rheumatoid factors: quantification in synovial fluid and ability to induce synovial mast cell histamine release.

Authors:  B Gruber; D Ballan; P D Gorevic
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

9.  Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.

Authors:  M Doherty; N Richards; J Hornby; R Powell
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

10.  Measurement of terminal complement complexes in rheumatoid arthritis.

Authors:  B P Morgan; R H Daniels; B D Williams
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.